|
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer
|
Écrit par Oana |
Clics : 13
|
|
Impact of biological matrix on inflammatory protein biomarker quantification based on targeted mass spectrometry
|
Écrit par Oana |
Clics : 15
|
|
Alzheimer's Disease: Advances in Drug Development
|
Écrit par Oana |
Clics : 15
|
|
Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods.
|
Écrit par Oana |
Clics : 14
|
|
PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ.
|
Écrit par Oana |
Clics : 16
|
|
Glucocorticoid-dependent REDD1 expression reduces muscle metabolism to enable adaptation under energetic stress
|
Écrit par Oana |
Clics : 11
|
|
Cyclophilin A enables specific HIV-1 Tat palmitoylation and accumulation in uninfected cells
|
Écrit par Oana |
Clics : 12
|
|
What sample preparation should be chosen for targeted MS monoclonal antibody quantification in human serum?
|
Écrit par Oana |
Clics : 10
|
|
Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation
|
Écrit par Oana |
Clics : 13
|
|
Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches.
|
Écrit par Oana |
Clics : 13
|
